rethinkPeptides Search
Menu
Research citation

The Long-Term Cost-Effectiveness of Oral Semaglutide Versus Lower-Cost Liraglutide in the UK.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

The Long-Term Cost-Effectiveness of Oral Semaglutide Versus Lower-Cost Liraglutide in the UK.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 16(4), 613-628

Citation

Elnaggar, Mohamed; Mansinho, Joana Nunes; Malkin, Samuel J P; Whitaker, Joseph; Hunt, Barnaby; Glah, Divina; MacLellan, Martina; Ali, Samina. (2025). The Long-Term Cost-Effectiveness of Oral Semaglutide Versus Lower-Cost Liraglutide in the UK.. Diabetes therapy : research, treatment and education of diabetes and related disorders, 16(4), 613-628. https://doi.org/10.1007/s13300-025-01691-1